Hcmed

As of December 31, 2025, Hcmed has 32.72M shares outstanding.

As of December 31, 2025, Hcmed maintains a current ratio of 4.81, meaning it holds 4.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 38.95, indicating elevated leverage, while an interest coverage ratio of -78.41 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -36.66, reflecting losses generated across the asset base. Inventory turnover of 7.84 indicates how many times Hcmed sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on February 24, 2026, Hcmed's stock has gained approximately 71.41% over the past 52 weeks. The 50-day moving average sits at 109.85, while the 200-day moving average is 75.79.

Over the twelve months ended December 31, 2025, Hcmed posted a gross margin of 24.86, reflecting its pricing power and cost economics. The operating margin of -119.37 and net profit margin of -125.82 provide insight into operational efficiency.

As of December 31, 2025, Hcmed has an Altman Z-Score of -2.16, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.